The Technical Analyst

Amerisourcebergen Corp [ABC]

Exchange: NYSE Sector: Healthcare Industry: Medical - Distribution

Amerisourcebergen Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

-0.23% $179.98

America/New_York / 29 aug 2023 @ 16:00

FIND ALL MARKETS FIND ALL STOCKS LISTED @ NYSE Live Signal Oslo Live Signal Nasdaq Live Signal Crypto

Amerisourcebergen Corp: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap:	36 150 mill
EPS:	8.21
P/E:	21.92
Earnings Date:	Oct 31, 2023
SharesOutstanding:	200.85 mill
Avg Daily Volume:	1.643 mill

RATING 2023-09-25
S
Strong Buy

RATINGS
Rating CashFlow:	Buy
Return On Equity:	Strong Buy
Return On Asset:	Buy
DE:	Strong Buy
P/E:	Strong Buy
Price To Book:	Strong Buy

QUARTER GROWTHS
	3/22	4/22	1/23	2/23	3/23	4/23
Revenue
Gr.Profit
Ebit
Asset
Debt

PE RATIO: COMPANY / SECTOR
1.42x
Company: PE 21.92 \| sector: PE 15.43

PE RATIO: COMPANY / INDUSTRY
5.29x
Company: PE 21.92 \| industry: PE 4.14

DISCOUNTED CASH FLOW VALUE
N/A
N/A

Expected Trading Range (DAY)
$ 184.57 - 189.87 ( +/- 1.42%)
ATR Model: 14 days

Insider Trading

Date	Person	Action	Amount	type
2024-01-15	Greenberg Lon R	Buy	1 340	Common Stock
2024-01-04	Battaglia Silvana	Buy	53	Common Stock
2024-01-04	Campbell Elizabeth S	Buy	58	Common Stock
2024-01-04	Donato Leslie E	Buy	40	Common Stock
2024-01-03	Krikorian Lazarus	Buy	252	Common Stock

INSIDER POWER
8.65
Last 100 transactions
Buy: 1 943 089 \| Sell: 1 627 704

Forecast: 01:40 - $186.40

Live Trading Signals (every 1 min)

SCORE
10.00
Buy

Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022

Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD

Volume Signals
Price	$179.98 (-0.23% )
Volume	0.806 mill
Avg. Vol.	1.643 mill
% of Avg. Vol	49.07 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Amerisourcebergen Corp

Last 12 Months

RSI

Intraday RSI14 chart for Amerisourcebergen Corp

Last 10 Buy & Sell Signals For ABC

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date	Signal	@	Closed	%

ABC

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Last 10 Buy Signals

Date	Signal	@
AKTUSD	May 9 - 03:45	$4.75
TETUSD	May 9 - 03:40	14.54
SCNSOLUSD	May 9 - 03:41	172.48
P2PSUSD	May 9 - 03:41	171.38
MSOLUSD	May 9 - 03:40	170.62
FUMOUSD	May 9 - 03:40	4 547.46
BALUSD	May 9 - 03:42	$3.48
YFIIUSD	May 9 - 03:39	$466.32
SFRXETHUSD	May 9 - 03:38	3 231.65
FTMUSD	May 9 - 03:38	$0.669

Latest Press Releases

2023-08-30 07:30:00 - Press Release

Amerisourcebergen Becomes Cencora, In Alignment With The Company's Growing Global Footprint And Central Role In Pharmaceutical Access And Care

Conshohocken, pa.--(business wire)--amerisourcebergen becomes cencora, in alignment with the company's growing global footprint and central role in pharmaceutical access and care.

2023-08-15 08:00:00 - Press Release

Amerisourcebergen Elects Werner Baumann And Lauren Tyler To Its Board Of Directors

Conshohocken, pa.--(business wire)--amerisourcebergen corporation (nyse: abc) today announced that its board of directors has elected werner baumann and lauren m. tyler as new independent directors, effective october 1, 2023. with the election of mr. baumann and ms. tyler, the board of directors will increase from ten to twelve members, ten of whom are independent. “we look forward to welcoming mr. baumann and ms. tyler to amerisourcebergen's board of directors. their experience at preeminent m.

2023-08-03 18:48:00 - Press Release

Walgreens Boots Alliance Sells Shares Of Amerisourcebergen Corporation For $1.85 Billion Of Initial Proceeds

Deerfield, ill.--(business wire)--walgreens boots alliance sells shares of amerisourcebergen corporation for $1.85 billion of initial proceeds.

2023-08-03 16:33:00 - Press Release

Amerisourcebergen Announces Registered Public Offering Of Common Shares And Common Share Repurchase

Conshohocken, pa.--(business wire)--amerisourcebergen corporation (nyse: abc) (the “company”) announced today a registered public offering of 10.5 million shares of common stock of the company in connection with walgreens boots alliance holdings llc (the “selling stockholder”) entering into prepaid variable share forward transactions (the “variable forward transactions”) relating to the company's common stock with certain counterparties (the “counterparties”). the company has been advised that,.

2023-08-02 06:30:00 - Press Release

Amerisourcebergen Reports Fiscal 2023 Third Quarter Results

Conshohocken, pa.--(business wire)--amerisourcebergen corporation (nyse: abc) today reported that in its fiscal year 2023 third quarter ended june 30, 2023, revenue increased 11.5 percent year-over-year to $66.9 billion. on the basis of u.s. generally accepted accounting principles (gaap), diluted earnings per share (eps) was $2.35 for the third quarter of fiscal 2023 compared to $1.92 in the prior year third quarter. adjusted diluted eps, which is a non-gaap financial measure that excludes ite.

Latest News

2023-08-29 14:17:19 - Zacks Investment Research

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Full Story

2023-08-03 20:54:27 - Forbes

Walgreens Sells AmerisourceBergen Shares To Raise $1.85 Billion To Pay Down Debt And Accelerate Health Strategy

Walgreens Boots Alliance has sold shares of AmerisourceBergen for initial proceeds of $2.85 billion, which will be used to accelerate the drugstore giant's healthcare strategy.

Full Story

2023-08-03 19:53:11 - Reuters

Walgreens sells $1.85 bln of AmerisourceBergen shares, further cutting stake

Walgreens Boots Alliance has sold some AmerisourceBergen Corp's shares for proceeds of about $1.85 billion, the U.S. drugstore chain said on Thursday, further cutting its ownership in the drug distributor to about 16%.

Full Story

2023-08-03 19:16:00 - Market Watch

Walgreens Boots Alliance sells shares of AmerisourceBergen for $1.85 billion

Drugstore chain Walgreens Boots Alliance Inc. WBA, -1.17% on Thursday said it sold shares of drug distributor AmerisourceBergen Corp. ABC, -0.04% for initial proceeds of $1.85 billion. Walgreens said it planned to use the proceeds it got from the deal largely to pay down debt and to handle general operations.

Full Story

2023-08-02 11:13:05 - Zacks Investment Research

AmerisourceBergen (ABC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for AmerisourceBergen (ABC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Full Story

2023-08-02 07:37:52 - Reuters

AmerisourceBergen forecasts upbeat annual profit as weight-loss drugs lift results

Drug distributor AmerisourceBergen raised its full-year profit forecast on Wednesday, as soaring demand for weight-loss drugs and specialty medicines helped soften the blow from a fall in COVID-related drug sales in the third quarter.

Full Story

2023-07-28 12:14:11 - Seeking Alpha

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

AmerisourceBergen has seen a 3x return on investment in the past 3 years, outperforming the market. I think it's a very solid company in pharma and healthcare distribution. Investing in high-quality companies when they are cheap is crucial for maximizing returns. AmerisourceBergen is a conservative and safe option in the pharma and healthcare industry, but has now reached a valuation of where I would consider it a "HOLD".

Full Story

2023-07-26 08:40:35 - Zacks Investment Research

Is a Beat Likely for AmerisourceBergen (ABC) in Q3 Earnings?

AmerisourceBergen's (ABC) fiscal third-quarter 2023 results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.

Full Story

2023-07-21 10:43:01 - Zacks Investment Research

AmerisourceBergen Corporation (ABC) Soars to 52-Week High, Time to Cash Out?

AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Full Story

2023-07-20 18:10:03 - Zacks Investment Research

Hunting for Growth Mixed with Value: Buy These 3 Stocks Now

Looking at three highly-ranked Zacks stocks that have outperformed the market over the last several years, while posting solid growth. All three stocks we dig into also offer investors great value at the moment.

Full Story

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.